Logo image of AKE.PA

ARKEMA (AKE.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:AKE - FR0010313833 - Common Stock

51.7 EUR
-0.15 (-0.29%)
Last: 12/3/2025, 12:15:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AKE. AKE was compared to 74 industry peers in the Chemicals industry. AKE has an average financial health and profitability rating. AKE has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AKE was profitable.
In the past year AKE had a positive cash flow from operations.
In the past 5 years AKE has always been profitable.
Each year in the past 5 years AKE had a positive operating cash flow.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

AKE has a Return On Assets (1.51%) which is in line with its industry peers.
AKE's Return On Equity of 2.90% is in line compared to the rest of the industry. AKE outperforms 54.05% of its industry peers.
AKE has a Return On Invested Capital (3.44%) which is comparable to the rest of the industry.
AKE had an Average Return On Invested Capital over the past 3 years of 5.57%. This is in line with the industry average of 6.87%.
Industry RankSector Rank
ROA 1.51%
ROE 2.9%
ROIC 3.44%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 2.22%, AKE is in line with its industry, outperforming 55.41% of the companies in the same industry.
In the last couple of years the Profit Margin of AKE has declined.
AKE has a Operating Margin (6.35%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of AKE has declined.
The Gross Margin of AKE (19.02%) is worse than 72.97% of its industry peers.
In the last couple of years the Gross Margin of AKE has remained more or less at the same level.
Industry RankSector Rank
OM 6.35%
PM (TTM) 2.22%
GM 19.02%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

AKE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
AKE has more shares outstanding than it did 1 year ago.
AKE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AKE has a worse debt to assets ratio.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 1.86 indicates that AKE is not a great score, but indicates only limited risk for bankruptcy at the moment.
AKE's Altman-Z score of 1.86 is on the low side compared to the rest of the industry. AKE is outperformed by 70.27% of its industry peers.
The Debt to FCF ratio of AKE is 16.70, which is on the high side as it means it would take AKE, 16.70 years of fcf income to pay off all of its debts.
AKE has a Debt to FCF ratio (16.70) which is in line with its industry peers.
A Debt/Equity ratio of 0.50 indicates that AKE is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.50, AKE is in line with its industry, outperforming 43.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.7
Altman-Z 1.86
ROIC/WACC0.72
WACC4.81%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

AKE has a Current Ratio of 2.73. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
AKE has a Current ratio of 2.73. This is amongst the best in the industry. AKE outperforms 81.08% of its industry peers.
A Quick Ratio of 1.92 indicates that AKE should not have too much problems paying its short term obligations.
AKE has a Quick ratio of 1.92. This is amongst the best in the industry. AKE outperforms 83.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.92
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2

3. Growth

3.1 Past

AKE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.40%.
Measured over the past 5 years, AKE shows a small growth in Earnings Per Share. The EPS has been growing by 0.10% on average per year.
The Revenue has been growing slightly by 0.32% in the past year.
Measured over the past years, AKE shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%

3.2 Future

Based on estimates for the next years, AKE will show a decrease in Earnings Per Share. The EPS will decrease by -2.13% on average per year.
AKE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.37% yearly.
EPS Next Y-35.91%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPS Next 5Y-2.13%
Revenue Next Year-4.84%
Revenue Next 2Y-1.36%
Revenue Next 3Y0.39%
Revenue Next 5Y1.37%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.04, the valuation of AKE can be described as reasonable.
AKE's Price/Earnings ratio is rather cheap when compared to the industry. AKE is cheaper than 90.54% of the companies in the same industry.
AKE is valuated cheaply when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 8.46 indicates a reasonable valuation of AKE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 93.24% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.22, AKE is valued rather cheaply.
Industry RankSector Rank
PE 10.04
Fwd PE 8.46
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 94.59% of the companies listed in the same industry.
78.38% of the companies in the same industry are more expensive than AKE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.32
EV/EBITDA 4.46
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

AKE's earnings are expected to decrease with -4.81% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)102.72
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.90%, AKE is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.13, AKE pays a better dividend. On top of this AKE pays more dividend than 94.59% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, AKE pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.9%

5.2 History

The dividend of AKE is nicely growing with an annual growth rate of 6.86%!
Dividend Growth(5Y)6.86%
Div Incr Years4
Div Non Decr Years4
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

129.52% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
The Dividend Rate of AKE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP129.52%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (12/3/2025, 12:15:00 PM)

51.7

-0.15 (-0.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners59.49%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap3.93B
Revenue(TTM)9.54B
Net Income(TTM)210.00M
Analysts73.33
Price Target65.98 (27.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.9%
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP129.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.64%
Min EPS beat(2)-8.67%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-18.44%
Max EPS beat(4)-1.73%
EPS beat(8)3
Avg EPS beat(8)-4.83%
EPS beat(12)7
Avg EPS beat(12)1.09%
EPS beat(16)11
Avg EPS beat(16)10.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)-15.03%
PT rev (3m)-16.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.26%
EPS NY rev (1m)-7.1%
EPS NY rev (3m)-9.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.07%
Revenue NY rev (1m)-1.12%
Revenue NY rev (3m)-1.92%
Valuation
Industry RankSector Rank
PE 10.04
Fwd PE 8.46
P/S 0.42
P/FCF 17.32
P/OCF 3.87
P/B 0.54
P/tB 1.84
EV/EBITDA 4.46
EPS(TTM)5.15
EY9.96%
EPS(NY)6.11
Fwd EY11.82%
FCF(TTM)2.98
FCFY5.77%
OCF(TTM)13.36
OCFY25.84%
SpS124.15
BVpS95.11
TBVpS28.16
PEG (NY)N/A
PEG (5Y)102.72
Graham Number104.98
Profitability
Industry RankSector Rank
ROA 1.51%
ROE 2.9%
ROCE 4.88%
ROIC 3.44%
ROICexc 3.86%
ROICexgc 7.22%
OM 6.35%
PM (TTM) 2.22%
GM 19.02%
FCFM 2.4%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexgc growth 3Y-19.33%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.7
Debt/EBITDA 2.56
Cap/Depr 95.75%
Cap/Sales 8.36%
Interest Coverage 17.14
Cash Conversion 71.35%
Profit Quality 108.1%
Current Ratio 2.73
Quick Ratio 1.92
Altman-Z 1.86
F-Score5
WACC4.81%
ROIC/WACC0.72
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
EPS Next Y-35.91%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPS Next 5Y-2.13%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%
Revenue Next Year-4.84%
Revenue Next 2Y-1.36%
Revenue Next 3Y0.39%
Revenue Next 5Y1.37%
EBIT growth 1Y-21.16%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year49.9%
EBIT Next 3Y20.73%
EBIT Next 5Y12.34%
FCF growth 1Y-64.53%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-26.48%
OCF growth 3Y7%
OCF growth 5Y-2.92%

ARKEMA / AKE.PA FAQ

What is the ChartMill fundamental rating of ARKEMA (AKE.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.


What is the valuation status of ARKEMA (AKE.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to ARKEMA (AKE.PA). This can be considered as Fairly Valued.


How profitable is ARKEMA (AKE.PA) stock?

ARKEMA (AKE.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of ARKEMA (AKE.PA) stock?

The Price/Earnings (PE) ratio for ARKEMA (AKE.PA) is 10.04 and the Price/Book (PB) ratio is 0.54.


How financially healthy is ARKEMA?

The financial health rating of ARKEMA (AKE.PA) is 5 / 10.